Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily

af Moskowitz, Craig H.
Udgivet i Blood Adv (2018)

Metabolic Tumor Volume in Lymphoma: Hype or Hope?

af Schöder, Heiko, Moskowitz, Craig H.
Udgivet i J Clin Oncol (2016)

Controversies in the Treatment of Lymphoma with Autologous Transplantation

af Moskowitz, Alison J., Moskowitz, Craig H.
Udgivet 2009

Transplant strategies in relapsed/refractory Hodgkin lymphoma

af Shah, Gunjan L., Moskowitz, Craig H.
Udgivet i Blood (2018)

The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy

af Lekakis, Lazaros J., Moskowitz, Craig H.
Udgivet i Hemasphere (2019)

Strategies for Recognizing and Managing Immune‐Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors

af Vardhana, Santosha, Cicero, Kara, Velez, Moises J., Moskowitz, Craig H.
Udgivet i Oncologist (2018)

Excellent Outcomes and Lack of Prognostic Impact of Cell of Origin for Localized Diffuse Large B-cell Lymphoma in the Rituximab Era

af Kumar, Anita, Lunning, Matthew A., Zhang, Zhigang, Migliacci, Jocelyn C., Moskowitz, Craig H., Zelenetz, Andrew D.
Udgivet i Br J Haematol (2015)

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

af Moskowitz, Alison J., Yahalom, Joachim, Kewalramani, Tarun, Maragulia, Jocelyn C., Vanak, Jill M., Zelenetz, Andrew D., Moskowitz, Craig H.
Udgivet 2010

Pre-Transplant FDG-PET Scan Lacks Prognostic Value in Chemosensitive B-Cell Non-Hodgkin Lymphoma Patients Undergoing Non-Myeloablative Allogeneic Stem Cell Transplantation

af Sauter, Craig S., Lechner, Lauren, Scordo, Michael, Zheng, Junting, Devlin, Sean M., Fleming, Stephen E., Castro-Malaspina, Hugo, Moskowitz, Craig H.
Udgivet i Biol Blood Marrow Transplant (2014)

Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era

af Vardhana, Santosha A., Sauter, Craig S., Matasar, Matthew J., Zelenetz, Andrew D., Galasso, Natasha, Woo, Kaitlin M., Zhang, Zhigang, Moskowitz, Craig H.
Udgivet i Br J Haematol (2016)

KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure

af Armand, Philippe, Kuruvilla, John, Michot, Jean-Marie, Ribrag, Vincent, Zinzani, Pier Luigi, Zhu, Ying, Marinello, Patricia, Nahar, Akash, Moskowitz, Craig H.
Udgivet i Blood Adv (2020)

Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B-cell Lymphoma Treated with Second-line Therapy and Intent to Transplant

af Vardhana, Santosha, Hamlin, Paul A., Yang, Joanna, Zelenetz, Andrew, Sauter, Craig S., Matasar, Matthew J., Ni, Andy, Yahalom, Joachim, Moskowitz, Craig H
Udgivet i Biol Blood Marrow Transplant (2018)

Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma

af Ulaner, Gary A., Goldman, Debra A., Sauter, Craig S., Migliacci, Jocelyn, Lilienstein, Joshua, Gönen, Mithat, Schöder, Heiko, Moskowitz, Craig H., Zelenetz, Andrew D.
Udgivet i Radiology (2015)

Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma

af Moskowitz, Alison J, Perales, Miguel-Angel, Kewalramani, Tarun, Yahalom, Joachim, Castro-Malaspina, Hugo, Zhang, Zhigang, Vanak, Jill, Zelenetz, Andrew D, Moskowitz, Craig H
Udgivet 2009

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013

af Ribrag, Vincent, Armand, Phillippe, Kuruvilla, John, Michot, Jean-Marie, Moskowitz, Craig H, Marinello, Patricia, Snyder, Ellen, Balakumaran, Arun, Shipp, Margaret A, Zinzani, Pier Luigi
Udgivet i J Immunother Cancer (2015)

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma

af Zinzani, Pier Luigi, Ribrag, Vincent, Moskowitz, Craig H., Michot, Jean-Marie, Kuruvilla, John, Balakumaran, Arun, Zhang, Yayan, Chlosta, Sabine, Shipp, Margaret A., Armand, Philippe
Udgivet i Blood (2017)

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma

af Sauter, Craig S., Matasar, Matthew J., Meikle, Jessica, Schoder, Heiko, Ulaner, Gary A., Migliacci, Jocelyn C., Hilden, Patrick, Devlin, Sean M., Zelenetz, Andrew D., Moskowitz, Craig H.
Udgivet i Blood (2015)

Phase II study of pembrolizumab (MK-3475) for relapsed/refractory classical Hodgkin Lymphoma (r/r cHL): keynote-087

af Chen, Robert, Armand, Phillippe, Fanale, Michelle A, Ribrag, Vincent, Zinzani, Pier Luigi, Ricart, Alejandro D, Thompson, Seth, Balakumaran, Arun, Molin, Daniel, Shipp, Margaret A, Moskowitz, Craig H
Udgivet i J Immunother Cancer (2015)

The Potential Benefit of Allogeneic over Autologous Transplantation in Patients with Very Early Relapsed and Refractory Follicular Lymphoma with Prior Remission Duration of ≤ 12 Mo...

af Lunning, Matthew A., Migliacci, Jocelyn C., Hilden, Patrick, Devlin, Sean M., Castro-Malaspina, Hugo, Giralt, Sergio, Perales, Miguel-Angel, Zelenetz, Andrew D., Moskowitz, Craig H., Sauter, Craig S.
Udgivet i Br J Haematol (2016)

A Comprehensive Assessment of Toxicities in Patients with CNS Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan and Cyclophosphamide Conditioning

af Scordo, Michael, Bhatt, Valkal, Hsu, Meier, Omuro, Antonio M., Matasar, Matthew J., DeAngelis, Lisa M., Dahi, Parastoo B., Moskowitz, Craig H., Giralt, Sergio A, Sauter, Craig S.
Udgivet i Biol Blood Marrow Transplant (2016)